| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3416102 | Microbes and Infection | 2007 | 6 Pages |
Abstract
Attenuated pre-erythrocytic stage malaria vaccines protect humans from sporozoite challenge. Current technology limits the feasibility of their commercial scale production and poses a significant risk of contamination with transmissible agents. Overcoming these barriers will be very challenging. In contrast, subunit vaccines appear quite feasible and show great promise as candidate malaria vaccines.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
W. Ripley Ballou,